Inventor · Cambridge, GB

Matthew Cooper

28Patents
4h-index
39Co-inventors
63Inventor score

Filing activity: Nov 2, 2001 → Jun 27, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US10538487B2 Sulfonylureas and related compounds and use of same Emerging Cross-Sectional Technologies 21 Active
US11130731B2 Sulfonylureas and related compounds and use of same Emerging Cross-Sectional Technologies 10 Active
US7078380B2 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements Chemistry; Metallurgy 6 Expired
US11370776B2 Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors Physics 5 Active
US11834433B2 Compounds Chemistry; Metallurgy 2 Active
US11434190B2 Inhibitors of SOX18 protein activity for treating angiogenesis-and/or lymphangiogenesis-related diseases Chemistry; Metallurgy 1 Active
US10280197B2 Discovery of the first selective C5A receptor 2 (C5L2/C5AR2) ligands Human Necessities 1 Active
US11858922B2 Sulfonylureas and related compounds and use of same Chemistry; Metallurgy 1 Active
US11905252B2 Compounds Chemistry; Metallurgy 0 Active
US11884645B2 Sulfonyl acetamides as NLRP3 inhibitors Human Necessities 0 Active
US11542255B2 Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors Chemistry; Metallurgy 0 Active
US11926600B2 Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors Chemistry; Metallurgy 0 Active
US12221434B2 Sulfonamide carboxamide compounds Chemistry; Metallurgy 0 Active
US11530200B2 Compounds Chemistry; Metallurgy 0 Active
US12012392B2 Sulfonamide carboxamide compounds Chemistry; Metallurgy 0 Active
US11845715B2 Sulfonylureas and related compounds and use of same General 0 Revoked
US12410116B2 Compounds and use thereof in methods of treatment Chemistry; Metallurgy 0 Active
US12030879B2 Sulfonyl acetamides as NLRP3 inhibitors Chemistry; Metallurgy 0 Active
US12304941B2 Suppression of cytokine release syndrome in chimeric antigen receptor cell therapy Chemistry; Metallurgy 0 Active
US11613542B2 Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors Chemistry; Metallurgy 0 Active
US12350349B2 Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptors Chemistry; Metallurgy 0 Active
US11981667B2 Sulfonamide carboxamide compounds Chemistry; Metallurgy 0 Active
US11840543B2 Compounds and uses Chemistry; Metallurgy 0 Active
US10947271B2 Antibacterial agents Emerging Cross-Sectional Technologies 0 Active
US12168653B2 Sulfonamide derivates as NLRP3 inhibitors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.